Tinnitus Drops
Generic Name: tinnitus drops
Brand Names:
Tinnitus Drops 2072
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Overview
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Uses
INDICATIONS For the temporary relief of noise in the ears, such as ringing, roaring, buzzing, hissing, or whistling.*
Dosage
DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day for up to 6 weeks. For immediate onset of symptoms, take 10 to 15 drops every 15 minutes up to 3 hours. For less severe symptoms, take 10-15 drops hourly up to 8 hours. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS Persistent symptoms may be a sign of a serious condition. If symptoms persist or are accompanied by a fever, persistent headache, dizziness, or loss of hearing, consult a doctor. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Pregnancy
If pregnant or breastfeeding, ask a healthcare professional before use.
Frequently Asked Questions
What is Tinnitus Drops used for?▼
INDICATIONS For the temporary relief of noise in the ears, such as ringing, roaring, buzzing, hissing, or whistling.*
Can I take Tinnitus Drops during pregnancy?▼
If pregnant or breastfeeding, ask a healthcare professional before use.
What are the important warnings for Tinnitus Drops?▼
WARNINGS Persistent symptoms may be a sign of a serious condition. If symptoms persist or are accompanied by a fever, persistent headache, dizziness, or loss of hearing, consult a doctor. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Related Medications
Mefloquine Hydrochloride
mefloquine hydrochloride
DESCRIPTION Mefloquine hydrochloride tablets, USP are an antimalarial agent available as 250 mg tablets of mefloquine hydrochloride (equivalent to 228 mg of the free base) for oral administration. Mefloquine hydrochloride, USP is a 4-quinolinemethanol derivative with the specific chemical name of (R*, S*)-(±)-α-2-piperidinyl-2,8-bis (trifluoromethyl)-4-quinolinemethanol hydrochloride. It is a 2-aryl substituted chemical structural analog of quinine.
Lifileucel
lifileucel
11 DESCRIPTION AMTAGVI (lifileucel) is a tumor-derived autologous T cell immunotherapy comprised of a suspension of tumor-derived T cells for intravenous infusion. AMTAGVI is manufactured from resected patient tumor tissue prosected from one or more tumor lesions. Immune cells derived from a patient's tumor(s) are expanded in cell culture, washed, formulated as a cell suspension, and cryopreserved.
Paltusotine
paltusotine
11 DESCRIPTION PALSONIFY tablets contain paltusotine hydrochloride, a somatostatin receptor agonist. Paltusotine is known chemically as 3-[4-(4-Amino-1-piperidinyl)-3-(3,5-difluorophenyl)-6-quinolinyl]-2-hydroxybenzonitrile hydrochloride. The molecular weight of paltusotine hydrochloride is 492.95 g/mol (C 27 H 22 F 2 N 4 O·HCl).
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.